Identification of treatment‐induced vulnerabilities in pancreatic cancer patients using functional model systems

Despite the advance and success of precision oncology in gastrointestinal cancers, the frequency of molecular‐informed therapy decisions in pancreatic ductal adenocarcinoma (PDAC) is currently neglectable. We present a longitudinal precision oncology platform based on functional model systems, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Peschke, Katja, Jakubowsky, Hannah, Schäfer, Arlett, Maurer, Carlo, Lange, Sebastian, Orben, Felix, Bernad, Raquel, Harder, Felix N, Eiber, Matthias, Öllinger, Rupert, Steiger, Katja, Schlitter, Melissa, Weichert, Wilko, Mayr, Ulrich, Phillip, Veit, Schlag, Christoph, Schmid, Roland M, Braren, Rickmer F, Kong, Bo, Demir, Ihsan Ekin, Friess, Helmut, Rad, Roland, Saur, Dieter, Schneider, Günter, Reichert, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988213/
https://www.ncbi.nlm.nih.gov/pubmed/35119792
http://dx.doi.org/10.15252/emmm.202114876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988213/
https://www.ncbi.nlm.nih.gov/pubmed/35119792
http://dx.doi.org/10.15252/emmm.202114876

Ejemplares similares